Functional activity of murine intestinal mucosal cells is regulated by the glucagon-like peptide-1 receptor

Peptides

Volumn 48, Issue , 2013, Pages 36-44

  Kedees, Mamdouh H ^a   Guz, Yelena ^a   Grigoryan, Marine ^a   Teitelman, Gladys ^a  

^a Downstate Health Sciences University   (United States)

Author keywords

Enteric neurons; Enterocytes; Glucagon like peptide 1 receptor; Paneth cells

Indexed keywords

AMIDE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; MESSENGER RNA; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CELL FUNCTION; CELLULAR DISTRIBUTION; COLON; CONTROLLED STUDY; EPITHELIUM CELL; ILEUM; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTESTINE CELL; INTESTINE FUNCTION; INTESTINE MUCOSA; L CELL; MOUSE; MUCOSA CELL; NONHUMAN; ONCOGENE C FOS; PANETH CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

MURINAE; MUS;

ENTERIC NEURONS; ENTEROCYTES; GLUCAGON LIKE PEPTIDE-1 RECEPTOR; PANETH CELLS;

ANIMALS; ENTEROCYTES; GENE EXPRESSION REGULATION; ILEUM; INTESTINAL MUCOSA; MICE; PANETH CELLS; PEPTIDE FRAGMENTS; PEPTIDES; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, GLUCAGON; TISSUE DISTRIBUTION; VENOMS;

EID: 84883080560     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.07.022     Document Type: Article

References (35)

1. Alvarez E, Martinez MD, Roncero I, Chowen JA, Garcia-Cuartero B, Gispert JD, et al. The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. Journal of Neurochemistry 2005;92:798-806. (Pubitemid 40229551)
2. Amato A, Cinci L, Rotondo A, Serio R, Faussone-Pellegrini MS, Vannucchi MG, et al. Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society 2010;22:664-e203.
3. Assimakopoulos SF, Papageorgiou I, Charonis A. Enterocytes' tight junctions: from molecules to diseases. World Journal of Gastrointestinal Pathophysiology 2011;2:123-37.
4. Barrera JG, D'Alessio DA, Drucker DJ, Woods SC, Seeley RJ. Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats. Diabetes 2009;58:2820-7.
5. Bertiaux-Vandaele N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, et al. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. American Journal of Gastroenterology 2011;106:2165-73.
6. Bjerknes M, Cheng H. Modulation of specific intestinal epithelial progenitors by enteric neurons. Proceedings of the National Academy of Sciences of the United States of America 2001;98:12497-502. (Pubitemid 33019974)
7. Carraro-Lacroix LR, Malnic G, Girardi AC. Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells. American Journal of Physiology Renal Physiology 2009;297:F1647-55.
8. Crajoinas RO, Oricchio FT, Pessoa TD, Pacheco BP, Lessa LM, Malnic G, et al. Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1. American Journal of Physiology Renal Physiology 2011;301:F355-63.
9. Drucker DJ. The biology of incretin hormones. Cell Metabolism 2006;3:153-65.
10. Fagone P, Jackowski S. Membrane phospholipid synthesis and endoplasmic reticulum function. Journal of Lipid Research 2009;50(Suppl.):S311-6.
11. Gershon MD. The enteric nervous system. Annual Review of Neuroscience 1981;4:227-72.
12. Grigoryan M, Kedees MH, Charron MJ, Guz Y, Teitelman G. Regulation of mouse intestinal L cell progenitors proliferation by the glucagon family of peptides. Endocrinology 2012;153:3076-88.
13. Gutzwiller JP, Hruz P, Huber AR, Hamel C, Zehnder C, Drewe J, et al. Glucagonlike peptide-1 is involved in sodium and water homeostasis in humans. Digestion 2006;73:142-50. (Pubitemid 44155916)
14. Hadjiyanni I, Baggio LL, Poussier P, Drucker DJ. Exendin-4 modulates diabetes onset in nonobese diabetic mice. Endocrinology 2008;149:1338-49. (Pubitemid 351397945)
15. Hassan M, Eskilsson A, Nilsson C, Jonsson C, Jacobsson H, Refai E, et al. In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera. Nuclear Medicine and Biology 1999;26:413-20. (Pubitemid 29254028)
16. Heller RS, Kieffer TJ, Habener JF. Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes 1997;46:785-91. (Pubitemid 27188255)
17. Holst JJ. The physiology of glucagon-like peptide 1. Physiological Reviews 2007;87:1409-39. (Pubitemid 350041474)
18. Kedees MH, Grigoryan M, Guz Y, Teitelman G. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia. Molecular and Cellular Endocrinology 2009;311:69-76.
19. Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacological Reviews 2008;60:470-512.
20. Korner M, Stockli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 2007;48:736-43. (Pubitemid 47604973)
21. Machholz E, Mulder G, Ruiz C, Corning BF, Pritchett-Corning KR. Manual restraint and common compound administration routes in mice and rats. Journal of Visualized Experiments: JoVE 2012.
22. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, et al. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 1996;45:257-61. (Pubitemid 26048675)
23. Panjwani N, Mulvihill EE, Longuet C, Yusta B, Campbell JE, Brown TJ, et al. GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(?/?) mice. Endocrinology 2013;154:127-39.
24. Parkes DG, Pittenr R, Jodka C, Smith P, Young A. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism: Clinical and Experimental 2001;50:583-9. (Pubitemid 32433049)
25. Perez-Tilve D, Gonzalez-Matias L, Alvarez-Crespo M, Leiras R, Tovar S, Dieguez C, et al. Exendin-4 potently decreases ghrelin levels in fasting rats. Diabetes 2007;56:143-51.
26. Portal MM, Ferrero GO, Caputto BL. N-Terminal c-Fos tyrosine phosphorylation regulates c-Fos/ER association and c-Fos-dependent phospholipid synthesis activation. Oncogene 2007;26:3551-8. (Pubitemid 46816755)
27. Schirra J, Sturm K, Leicht P, Arnold R, Goke B, Katschinski M. Exendin(9- 39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans. Journal of Clinical Investigation 1998;101:1421-30. (Pubitemid 28166840)
28. Schultheis PJ, Clarke LL, Meneton P, Miller ML, Soleimani M, Gawenis LR, et al. Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger. Nature Genetics 1998;19:282-5. (Pubitemid 28309344)
29. Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop DS, Moller M, et al. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. The American Journal of Physiology 1996;271:R848-56.
30. Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proceedings of the National Academy of Sciences of the United States of America 1992;89: 8641-5.
31. Vahl TP, Tauchi M, Durler TS, Elfers EE, Fernandes TM, Bitner RD, et al. Glucagonlike peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007;148:4965-73. (Pubitemid 47481523)
32. Vuguin PM, Kedees MH, Cui L, Guz Y, Gelling RW, Nejathaim M, et al. Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology 2006;147: 3995-4006. (Pubitemid 44268351)
33. Washington MC, Raboin SJ, Thompson W, Larsen CJ, Sayegh AI. Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor. Brain Research 2010;1344:124-33.
34. Weiser MM, Ryzowicz S, Soroka CJ, Albini B. In vitro translation of rat intestinal RNA prepared from isolated villus and crypt cells and from the epitheliumdenuded intestine. Synthesis of intestinal basement membrane. Transactions of the Association of American Physicians 1987;100:316-28.
35. Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, et al. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. Journal of Clinical Investigation 2002;110:43-52. (Pubitemid 34743464)